Abrezekimab, CAS 2043952-59-4

Product Description: Abrezekimab (VR 942) contains CDP7766, a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. Abrezekimab can be used in research of asthma[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Burgess G, et, al. Randomized study of the safety and pharmacodynamics of inhaled interleukin-13 monoclonal antibody fragment VR942. EBioMedicine. 2018 Sep;35:67-75.

CAS Number: 2043952-59-4

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Interleukin Related

• Artikelnummer: MEXHY-P99417-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99417-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK